Aptorum Group Files Latest S-4 Amendment for DiamiR Reverse Merger, Details Shareholder Vote on Dilutive Proposals

summarizeSummary

Aptorum Group filed its latest S-4 amendment, detailing the upcoming shareholder vote on a reverse merger with DiamiR Biosciences, which includes a reverse stock split and significant dilution for current shareholders, as the company seeks to address its going concern status and maintain its Nasdaq listing.

check_boxKey Events

• Reverse Merger Update

  This Pre-Effective Amendment No. 4 to the S-4 filing details the proposed reverse merger with DiamiR Biosciences, where DiamiR stockholders will own approximately 70% of the combined company, and existing Aptorum shareholders 30%.

• Shareholder Vote Scheduled

  A Special Meeting on June 9, 2026, will address proposals including a reverse stock split (at a ratio between 1:2 and 1:10), domestication to Delaware, issuance of shares for the merger, and a new 4.5 million share incentive plan.

• Guaranteed Approval

  CEO Ian Huen, holding 86.71% of Aptorum's total voting power, has signed an agreement to vote in favor of all proposals, ensuring their approval without the need for other shareholder votes.

• Going Concern & Nasdaq Compliance

  The company's auditor has expressed substantial doubt about its ability to continue as a going concern, and the proposed reverse stock split is intended to help meet Nasdaq's minimum bid price requirement for continued listing.

auto_awesomeAnalysis

This filing provides the latest comprehensive details for Aptorum Group's proposed reverse merger with DiamiR Biosciences, including critical shareholder proposals for a reverse stock split, domestication to Delaware, and the issuance of shares that will result in existing Aptorum shareholders owning only 30% of the combined entity. The company continues to operate under a going concern warning, making this merger a crucial, albeit highly dilutive, path for its survival and continued Nasdaq listing. The CEO's controlling vote ensures all proposals will pass.